GSK is officially cutting ties with Ideaya Biosciences, handing back two clinical programs as part of the termination of a 2020 licensing agreement. The breakup was initiated by GSK on Dec. 4, Ideaya ...

Among seven new medicines recommended for approval by the EMA's human medicine advisory committee at its latest meeting is GSK's depemokimab, a long-acting anti-IL-5 antibody for severe asthma and an ...

GSK plc (NYSE:GSK) is one of the best pharma stocks to invest in. J.P. Morgan analyst Richard Vosser maintained a Sell rating on GSK plc (NYSE:GSK) on December 8, setting a price target of £17.00. Is ...

GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won European regulatory approval for two inflammatory disease indications. The European Medicines Agency's ...

With an increase in the antimicrobial resistance to therapies for gonorrhea, doctors have been left with fewer options to treat the sexually transmitted infection (STI), which strikes more an 80 ...

LONDON, Dec 16 (Reuters) - The U.S. health regulator has approved GSK's (GSK.L), opens new tab add-on treatment for severe asthma, offering a less frequently dosed option, but rejected its use for ...

Rival European pharma giants Sanofi and GSK have both forged new partnerships to bolster their preclinical research. Paris-based Sanofi is investing in a U.S. biotech’s autoimmune research, while GSK ...

College of Surgeons of East, Central and Southern Africa (COSECSA) President Prof Laston Chikoya awards Honorary Fellowship to Smile Train President and CEO Susannah Schaefer as Secretary General of ...

Emma Walmsley’s praise for US pharmaceutical market piles pressure on UK government Business live – live updates The chief executive of GSK has declared that the US is the best place for ...

Dec 11 (Reuters) - The U.S. Food and Drug Administration said on Thursday it has expanded the use of GSK's (GSK.L), opens new tab Blujepa as an oral treatment for gonorrhea, a common sexually ...

GSK (GSK.L) continues to strengthen its oncology portfolio, this time with a new regulatory designation for risvutatug rezetecan in the US and a cancer drug discovery collaboration with UK-based ...

It’s understandable why millennials feel like they’re constantly being mocked on the internet, from the way they wear socks, how they decorate their home, and even the dreaded millennial pause. But ...